Team Named to Create Proteomic Stem Cell Research Standards for Drug Development | GenomeWeb
A team of six scientists has been formed to investigate the use of proteomic methods to evaluate stem cells in drug-development efforts as part of an initiative sponsored by the Human Proteome Organization and the International Society for Stem Cell Research.
The initiative, called the Proteome Biology of Stem Cells, is expected to last a decade. The task of the group will be to develop standards that can be applied to stem cells for use in drug development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.